Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update

Eloxx Pharmaceuticals (ELOX) Reports Q2 Loss of $0.42/Share

August 7, 2018 4:49 PM EDT

Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q2 EPS of ($0.42), versus ($1.04) reported last year.

For earnings history and earnings-related data on Eloxx Pharmaceuticals (ELOX) click here.

... More